Target Name: NRIP3
NCBI ID: G56675
Review Report on NRIP3 Target / Biomarker Content of Review Report on NRIP3 Target / Biomarker
NRIP3
Other Name(s): Nuclear receptor interacting protein 3 | C11orf14 | NRIP3_HUMAN | Nuclear receptor-interacting protein 3 | NY-SAR-105 | nuclear receptor interacting protein 3 | Sarcoma antigen NY-SAR-105 | sarcoma antigen NY-SAR-105

NRIP3: A Nuclear Receptor Interacting Protein 3 for Drug Targeting and Biomarker Development

Introduction

Nuclear receptor interacting protein 3 (NRIP3) is a protein that plays a crucial role in nuclear receptor signaling pathways. It is a 22-kDa transmembrane protein that consists of an N-terminal alpha-helix, a central beta-coil, a C- terminal T-loop and two acidic amino acid side chains of the C-terminal. NRIP3 plays an important role in a variety of physiological processes, such as cell proliferation, apoptosis, differentiation and tumor formation. In recent years, scientists have discovered the application value of NRIP3 in drug development and biomarker detection. This article will review the structure, function, drug targets of NRIP3 and its application in drug development and biomarker detection.

1. Structure and function

1. Structure

NRIP3 has a unique secondary structure. It consists of two main functional domains and two secondary functional domains. The functional domain includes an N-terminal 伪-helix, a central 尾-coil, and a C-terminal T-loop. The secondary functional domain includes an N-terminal 伪-helix, a central 尾-coil, and a C-terminal acidic amino acid side chain. The interaction between these functional domains gives NRIP3 a high degree of steric accessibility and ligand-binding ability, which is beneficial to its role in a variety of physiological processes.

2. Function

The key role played by NRIP3 in various physiological processes makes it a potential drug target. First, NRIP3 plays a role in cell proliferation, apoptosis, differentiation and tumor formation. For example, NRIP3 can inhibit cell proliferation and promote cell apoptosis, thereby playing a certain role in tumorigenesis. Secondly, NRIP3 plays a role in signal transduction pathways, such as the regulation of cell cycle, apoptosis, cell proliferation and differentiation, etc. In addition, NRIP3 is also involved in a variety of important biological processes, such as cell signaling, cell adhesion, cell migration, and cell proliferation.

2. Drug Targets

1. Inhibit cell proliferation

The inhibitory effect of NRIP3 on cell proliferation is mainly reflected in inhibiting the formation of spindle and the progression of cell mitosis. By inhibiting spindle formation, NRIP3 can prevent the separation of chromosomes in the spindle, resulting in abnormal number of chromosomes in the nucleus and abnormal intracellular proliferation. In addition, NRIP3 can also inhibit spindle-dependent kinases in the cell cycle, thereby inhibiting the cell cycle and preventing cells from entering the S phase of the cell cycle, resulting in inhibition of cell proliferation.

2. Anti-tumor effect

The anti-tumor role of NRIP3 is mainly reflected in inhibiting the growth, metastasis and angiogenesis of tumor cells. First, NRIP3 can prevent tumor cell proliferation by inhibiting spindle formation of tumor cells. Secondly, NRIP3 can also inhibit the metastasis of tumor cells and hinder the metastasis of tumor cells by inhibiting the invasiveness of tumor cells. Finally, NRIP3 can also inhibit the angiogenesis of tumor cells, thereby blocking the source of funds for tumor cells, thereby inhibiting the growth and metastasis of tumor cells.

3. Anti-apoptotic effect

The role of NRIP3 in anti-apoptosis is mainly reflected in inhibiting apoptosis. NRIP3 can inhibit apoptosis by regulating the expression of intracellular signaling molecules. Specifically, NRIP3 can bind to intracellular apoptosis signaling molecules, thereby inhibiting the transmission of apoptotic signals, thereby extending cell life and improving cell apoptosis resistance.

3. Biomarker detection

1. Application value

NRIP3 has wide application value in drug development and biomarker detection. First, NRIP3, as a drug target, can be used to screen anti-tumor drugs. Since NRIP3 plays an important role in tumorigenesis, inhibiting the activity of NRIP3 can effectively inhibit the growth and metastasis of tumor cells. Secondly, NRIP3 can also be detected as a tumor biomarker. By detecting the content of NRIP3 in the blood, the development of tumors can be monitored in real time, providing a basis for early diagnosis and treatment of tumors.

2. Detection method

Currently, NRIP3 detection methods mainly include Western blotting, Western Blot, immunofluorescence staining, and enzyme-linked reaction. Among them, Western blotting is a commonly used detection method, which can detect NRIP3

Protein Name: Nuclear Receptor Interacting Protein 3

The "NRIP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NRIP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NRIP3-DT | NRIR | NRK | NRL | NRM | NRN1 | NRN1L | NRON | NRP1 | NRP2 | NRROS | NRSN1 | NRSN2 | NRSN2-AS1 | NRTN | NRXN1 | NRXN2 | NRXN2-AS1 | NRXN3 | NSA2 | NSA2P2 | NSD1 | NSD2 | NSD3 | NSDHL | NSF | NSFL1C | NSFP1 | NSG1 | NSG2 | NSL complex | NSL1 | NSMAF | NSMCE1 | NSMCE1-DT | NSMCE2 | NSMCE3 | NSMCE4A | NSMF | NSRP1 | NSUN2 | NSUN3 | NSUN4 | NSUN5 | NSUN5P1 | NSUN5P2 | NSUN6 | NSUN7 | NT5C | NT5C1A | NT5C1B | NT5C1B-RDH14 | NT5C2 | NT5C3A | NT5C3AP1 | NT5C3B | NT5CP2 | NT5DC1 | NT5DC2 | NT5DC3 | NT5DC4 | NT5E | NT5M | NTAN1 | NTAQ1 | NTF3 | NTF4 | NTHL1 | NTM | NTMT1 | NTMT2 | NTN1 | NTN3 | NTN4 | NTN5 | NTNG1 | NTNG2 | NTPCR | NTRK1 | NTRK2 | NTRK3 | NTRK3-AS1 | NTS | NTSR1 | NTSR2 | NuA4 histone acetyltransferase (HAT) complex | NUAK Family SNF1-like Kinase (nonspcified subtype) | NUAK1 | NUAK2 | NUB1 | NUBP1 | NUBP2 | NUBPL | NUCB1 | NUCB2 | NUCKS1 | Nuclear factor interleukin-3-regulated protein-like | Nuclear factor of activated T-cells | Nuclear Pore Complex | Nuclear Receptor ROR